Danaher Corporation $DHR Stock Sold by Axxcess Wealth Management LLC

Key Points

• Axxcess Wealth Management cut its Danaher stake by 89.4% in the third quarter, selling 17,147 shares and retaining 2,037 shares valued at approximately $451,000. Institutional investors and hedge funds collectively own 79.05% of Danaher.
• Danaher reported quarterly earnings of $2.11 per share, beating the $1.92 consensus estimate, while revenue rose 8.3% year over year to $6.55 billion. The company also declared a quarterly dividend of $0.40 per share, representing a 0.7% annualized yield.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $242.91; TD Cowen and Goldman Sachs raised their targets to $270 and $275, respectively. Shares were trading near $230, with a P/E ratio of 37.70.

Axxcess Wealth Management LLC trimmed its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 89.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,037 shares of the conglomerate's stock after selling 17,147 shares during the quarter. Axxcess Wealth Management LLC's holdings in Danaher were worth $451,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in shares of Danaher in the 2nd quarter worth approximately $10,492,520,000. Wellington Management Group LLP raised its stake in Danaher by 10.4% during the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate's stock worth $3,108,031,000 after acquiring an additional 1,542,310 shares during the period. Jupiter Topco LLC acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $1,456,317,000. Generation Investment Management LLP bought a new stake in Danaher in the second quarter valued at $1,287,949,000. Finally, Bank of America Corp DE bought a new stake in Danaher in the second quarter valued at $993,846,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Down 0.1%

Shares of DHR stock opened at $230.36 on Monday. The stock has a 50-day simple moving average of $216.32 and a 200 day simple moving average of $197.39. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The stock has a market capitalization of $162.07 billion, a P/E ratio of 37.70, a P/E/G ratio of 2.89 and a beta of 0.76. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $1.92 by $0.19. The firm had revenue of $6.55 billion for the quarter, compared to analysts' expectations of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. Danaher's revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.89 earnings per share. On average, sell-side analysts expect that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher's dividend payout ratio is 26.19%.

Analysts Set New Price Targets

Several research firms have recently commented on DHR. TD Cowen upped their price target on shares of Danaher from $255.00 to $270.00 and gave the stock a "buy" rating in a research report on Thursday. The Goldman Sachs Group reaffirmed a "buy" rating and issued a $275.00 price objective on shares of Danaher in a report on Thursday. Evercore reiterated an "outperform" rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and a consensus target price of $242.91.

More Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher reported third-quarter adjusted earnings of $2.11 per share, above the $1.92 analyst consensus, while revenue reached approximately $6.55 billion. Revenue increased 8.3% year over year, and management raised its full-year 2026 adjusted EPS outlook. Danaher 3Q Net Up Sharply as Company Boosts 2026 Adjusted EPS View
• Positive Sentiment: Analysts raised their valuation targets following the results. TD Cowen and JPMorgan lifted targets to $270, Goldman Sachs raised its target to $275, Stifel increased its target to $260, and Robert W. Baird raised its target to $254. The firms maintained bullish ratings, including Buy, Overweight and Outperform. Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
• Positive Sentiment: Management highlighted margin strength, improved execution and an increased focus on innovation and artificial intelligence, factors analysts viewed as supporting a better longer-term outlook. Danaher Earnings Call Highlights Margin Strength, AI Push
• Neutral Sentiment: Despite the earnings beat and higher targets, shares declined in the immediate post-results reaction, suggesting investors may have already priced in much of the improvement. A recent valuation comparison also frames DHR as a stock for investors weighing quality and growth against its relatively elevated valuation. Danaher Q3 Recap: Decent Results, Still A Hold
• Negative Sentiment: Danaher’s new CEO emphasized the need for better execution and innovation. TD Cowen cited tariff pressure and a cautious 2027 outlook, creating uncertainty beyond the raised 2026 guidance and helping explain why the stock did not fully respond to the strong quarterly report. Danaher Posts First Earnings Under New CEO

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.